BBRY stock has been one of the best performers of 2014, but don't buy the hype. If you believe the assets have value, buy the bonds instead. More
MRK: Merck Stock a Strong Performer In the Pharma Space
Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More
January 2014: The 5 Best New iPhone Apps
Every month brings new iPhone apps with it. Check out the 5 best new iPhone apps including the photo-editing app Faded and more. More
BMY Pummeled After Earnings, But Bristol-Myers Squibb Stock Still a Buy
Bristol-Myers Squibb stock has a lot going for it, like the company's newfound focus on hepatitis C, oncology and immunotherapy. But BMY still might need time to reflect that potential. More
Marijuana News: Legalizing Weed May Lead to More Potent Pot
A recent study has discovered that legalizing weed may result in pot becoming more potent. The study found increased THC levels in areas where pot is legal. More
Xerox Delivers: 13 Dividend Stocks Increasing Payouts
Xerox surprised shareholders with a nice bump up in its dividend, one of 13 dividend stocks that saw dividend increases during the week of January 20. More
